Skip to content
ACB Aurora Cannabis Inc NASDAQ
1.02 USD 4.64% +0.05
OPEN 0.98
DAY RANGE 1.04 - 0.96
VOLUME 33695
52 WEEK RANGE 4.90 - 0.82
Interactive Brokers Logotype

Buy ACB stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 316.4M
Enterprise value 233.7M
Trailing pe -0.12765957446809
Forward pe -5.7058825
Peg ratio -5.7058825
Price to sales ttm 1.5031742
Price to book mrq 0.5237581
Enterprise to revenue 1.483
Enterprise to ebitda -1.893


Fiscal year ends 2022-06-30
Most recent quarter 2022-06-30
Profit margin 0.095893629229372
Operating margin -1.0849199
Return on assets ttm -0.07653
Return on equity ttm -1.34224
Income statement
Revenue ttm 157.5M
Revenue per share ttm 0.875
Quarterly revenue growth -0.18
Gross profit ttm 15.9M
Ebitda -123414159
Net income to common ttm -1315284116
Diluted eps ttm -4.702
Balance sheet
Total cash mrq 276.7M
Total cash per share mrq 1.14
Total debt mrq 243.7M
Total debt to equity mrq 54.763
Current ratio mrq 4.067
Book value per share mrq 1.852
Cash flow
Operating cash flow ttm -88544628
Levered free cash flow ttm -81332660

Stock statistics

Shares outstanding 324.3M
Float shares 307.5M
Avg 10 volume 7.1M
Avg 30 volume 8M
Shares short 35.9M
Short ratio 3.05
Percent held by insiders 0.00071999995
Percent held by institutions 0.20959999

Stock price summary

Fifty two week low 0.821
Fifty two week high 4.9
Fifty two week change -285.222
Beta 3.017042
Day 50 ma 1.10702
Day 200 ma 1.601405

Dividends and splits

Dividend date 2020-05-11
Last split factor 1-for-12 split
Last split date 2020-05-11

Aurora Cannabis Inc. (ACB) Company Profile

Aurora Cannabis Inc. is a Canadian licensed cannabis producer with headquarters in Edmonton. Aurora was founded on December 21, 2006, by Terry Booth, Steve Dobler, Dale Lesack, and Chris Mayerson. The company went public on October 23, 2018, and it trades on the New York Stock Exchange (NYSE) under the ticker ACB.

Through its subsidiaries, Aurora Cannabis engages in the production and distribution of medical cannabis products worldwide. The company structure is vertically integrated and horizontally diversified across several segments of the cannabis value chain.

The chain includes facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. Furthermore, Aurora produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.

It also sells vaporizers; consumable vaporizer accessories. The company engages in developing medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and the operation of CanvasRX.

Aurora Cannabis main competitors

  • Aphria
  • The Cronos Group
  • CannTrust Holdings
  • OrganiGram Holdings

Key Aurora Cannabis milestone

In January 2018, Aurora became the first private company to earn the rights to supply the Italian market through its German subsidiary Pedanios. According to the company, the first tender consisted of three lots of different cannabinoid profiles amounting to 100 kg.

In November 2019, Aurora opened an 11,000 square foot flagship retail center in West Edmonton Mall. The space is the largest retail outlet in Canada.

In March 2018, Aurora announced the completion of their acquisition of Cannimed, with both parties agreeing to the transaction based on friendly terms. With the agreement, Aurora’s total patient count to 42,000 registered cannabis patients in Canada.

Aurora Cannabis Frequently Asked Questions

Does Aurora Cannabis pay dividends?

Aurora Cannabis does not pay traditional dividends to investors.

Has Aurora split its stock?

Since going public, Aurora has split its stock once. 

In which countries does Aurora cannabis operate?

Aurora Cannabis had eight licensed production facilities, five sales licenses, and operations in 25 countries.